NVIDIA introduces an open-model infrastructure toolkit to transform general AI into specialized, autonomous research assistants for biology, chemistry, and genomics.
NVIDIA has officially announced the BioNeMo Agent Toolkit, a specialized suite of domain-specific tools and open models engineered to power autonomous AI agents in the life sciences sector. Built on a foundation of over a decade of NVIDIA’s accelerated computing libraries, the toolkit allows developers and frontier AI labs—including OpenAI and Anthropic—to transition general-purpose LLMs into active scientific research partners.
The toolkit addresses a major operational bottleneck: general AI platforms frequently struggle with the precise structural inputs, multi-step dependencies, and complex biological meanings required for scientific computing. By transforming specialized libraries into agent-callable tools, the toolkit enables AI agents to execute, reason through, and iterate on complex workflows. This includes virtual drug screening, genomic variant analysis, medical imaging synthesis, and de novo protein binder design.
Architecturally, the toolkit integrates core infrastructure including Nemotron open models for foundational scientific reasoning, NemoClaw blueprints for data privacy, and the OpenShell runtime to execute commands in secure environments.
A massive ecosystem of over 50 industry leaders, including Eli Lilly, Snowflake, Databricks, and Schrödinger, are already adopting the platform. Furthermore, open-science institutions like the University of Washington’s Institute for Protein Design are leveraging the toolkit to scale open-source frontier models, notably doubling the runtime performance of the state-of-the-art RoseTTAFold3 biodesign model.
The BioNeMo Agent Toolkit and its underlying skills are openly accessible to developers today via GitHub and NVIDIA’s developer resource channels.
